How big is the North America Blood Glucose Monitoring Market?

March 2023: Modified Abbott CGM sensors scored FDA nod for use in automated insulin delivery systems.
December 2022: Dexcom, a company that manufactures continuous glucose monitors (CGMs) for blood sugar management, announced the FDA approval for their next-generation product, the Dexcom G7 CGM. The G7 is approved for people with all types of diabetes from ages two years and older.

The North America Blood Glucose Monitoring Market size is expected to reach USD 15.51 billion in 2024 and grow at a CAGR of 13.13% to reach USD 28.74 billion by 2029. Read More

What is the current North America Blood Glucose Monitoring Market size?

In 2024, the North America Blood Glucose Monitoring Market size is expected to reach USD 15.51 billion. Read More

Who are the key players in North America Blood Glucose Monitoring Market?

Dexcom, Johnson & Johnson, Medtronics, F. Hoffmann-La Roche AG and Abbott Diabetes Care are the major companies operating in the North America Blood Glucose Monitoring Market. Read More

What years does this North America Blood Glucose Monitoring Market cover, and what was the market size in 2023?

In 2023, the North America Blood Glucose Monitoring Market size was estimated at USD 13.71 billion. The report covers the North America Blood Glucose Monitoring Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Blood Glucose Monitoring Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

North America Blood Glucose Monitoring Companies

This report lists the top North America Blood Glucose Monitoring companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the North America Blood Glucose Monitoring industry.